These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9067721)

  • 1. Expression of cathepsin-D, CA125 and epidermal growth factor receptor in imprint smears of ovarian carcinoma.
    Athanassiadou P; Sakellariou V; Michalas S; Petrakakou E; Zerva C; Athanassiades P; Aravantinos D
    Gynecol Obstet Invest; 1997; 43(2):125-30. PubMed ID: 9067721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical localization of Cathepsin D and CA 125 in ovarian cancer.
    Athanassiadou P; Sakellariou V; Michalas S; Petrakakou E; Athanassiades P; Aravantinos D
    Int J Gynaecol Obstet; 1997 Jan; 56(1):31-7. PubMed ID: 9049692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factor.
    Scambia G; Benedetti P; Ferrandina G; Battaglia F; Baiocchi G; Mancuso S
    Br J Cancer; 1991 Jul; 64(1):182-4. PubMed ID: 1854619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D immunoreactivity in ovarian cancer: correlation with prognostic factors.
    Athanassiadou P; Sakellariou V; Petrakakou E; Athanassiades P; Zerva C; Liossi A; Michalas S
    Pathol Oncol Res; 1998; 4(2):103-7. PubMed ID: 9654594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
    Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
    Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
    Göhring UJ; Scharl A; Ahr A
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of node-negative breast cancer patients with low histological grade tumors.
    Gaci Z; Bouin-Pineau MH; Gaci M; Daban A; Ingrand P; Métayé T
    Int J Oncol; 2001 Apr; 18(4):793-800. PubMed ID: 11251176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of cathepsin D and pS2 in imprint smears of breast carcinoma.
    Athanassiadou PP; Athanassiades PH; Davaris P; Petrakakou EI; Zerva CI; Kyrkou KA
    Cytopathology; 1998 Aug; 9(4):240-7. PubMed ID: 9710694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS; McKay JW; Stitt LW; Tokmakejian S; Haines DS
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
    Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
    J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA125 and thyroglobulin staining in papillary carcinomas of thyroid and ovarian origin is not completely specific for site of origin.
    Keen CE; Szakacs S; Okon E; Rubin JS; Bryant BM
    Histopathology; 1999 Feb; 34(2):113-7. PubMed ID: 10064389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients.
    Fischer-Colbrie J; Witt A; Heinzl H; Speiser P; Czerwenka K; Sevelda P; Zeillinger R
    Anticancer Res; 1997; 17(1B):613-9. PubMed ID: 9066588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
    Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
    Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary.
    Nolan LP; Heatley MK
    Int J Gynecol Pathol; 2001 Apr; 20(2):155-9. PubMed ID: 11293161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H; Itoh Y; Kuzushima T; Yamashita H; Iwata H; Toyama T; Hara Y; Kobayashi S
    Cancer Detect Prev; 1997; 21(1):29-35. PubMed ID: 9043760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 15-3 serum levels in patients with ductal breast carcinoma: relationship with clinicopathological parameters and tumor markers.
    González-Sistal A; Arias JI; Ruibal A
    Int J Biol Markers; 2012; 27(1):47-52. PubMed ID: 21928245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.